Company Search:
Advanced Search
Sponsored Links
Apex Biotechnology Corporation Company Snapshot
Apex Biotechnology Corporation operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Apex Biotechnology with three other companies in this sector in TAIWAN : Bionime Corporation (2019 sales of 2.17 billion Taiwanese Dollars [US$73.92 million] of which 100% was Medical Department), OK Biotech Co Ltd (1.24 billion Taiwanese Dollars [US$42.23 million] of which 100% was Ok Biotech Co Ltd), and Eps Bio Technology Corp (459.35 million Taiwanese Dollars [US$15.63 million] ).

Sales Analysis. During the year ended December of 2019, sales at Apex Biotechnology were 2.20 billion Taiwanese Dollars (US$74.81 million). This is an increase of 7.6% versus 2018, when the company's sales were 2.04 billion Taiwanese Dollars . This was the third consecutive year of growth at Apex Biotechnology. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 61.0% in 2019, from 98.67 million Taiwanese Dollars to 158.88 million Taiwanese Dollars . Apex Biotechnology also saw significant increases in sales in Test Strip (up 11.0% to 1.30 billion Taiwanese Dollars ) . Not all segments of Apex Biotechnology experienced an increase in sales in 2019: sales of Test Suite fell 12.0% to 351.33 million Taiwanese Dollars .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Apex Biotechnology Corporation
  Stock Performance Chart for Apex Biotechnology Corporation
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 28.80
(Figures in Taiwanese Dollars )
1 Week 8.1%   13 Weeks -0.9%  
4 Weeks 23.3%   52 Weeks 0.7%  
Apex Biotechnology Corporation Key Data:
  Ticker: 1733 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2019 Sales 2,198,862,000
(Year Ending Jan 2020).
Employees: 641
  Currency: Taiwanese Dollars Market Cap: 2,869,833,600
  Fiscal Yr Ends: December Shares Outstanding: 99,647,000
  Share Type: Gu Closely Held Shares: 13,232,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.